Retroperitoneal lymphadenectomy

Testicular cancer is the most common malignancy in men aged 15 to 35 years. The first step in identifying the disease is orchiectomy (removal of the testicle). Then, depending on the histological type and the extension, follow-up, chemotherapy, radiation and retroperitoneal lymphadenectomy are recommended.

Retroperitoneal lymphadenectomy is appropriate for:

1. Non-seminomatous tumors with lymph node metastases
2. Seminomas that did not respond to radiotherapy
3. Removal of residual masses after chemotherapy

Until now, this specific operation – due to the high morbidity that characterized it and the complications it caused – was rarely performed.

Recently, however, minimally invasive robotic surgery has allowed these surgeries to be performed with greater safety and efficacy. The technique of maintaining the sympathetic neural network (nerve-sparing) now prevents 97% of patients from recurrent ejaculation, which until now has been an important obstacle to the later life of young patients.

Advantages of retroperitoneal lymphadenectomy

• Recurrent ejaculation is prevented
• Hospitalization is reduced to 1 day (from 5-7 days)
• Return to everyday life in 15 days (from 2 months)

Our team is the only one in Greece that performs this demanding operation robotically in collaboration with the internationally renowned French urologist Jean-Luc Hoepffner, who has one of the largest patient series internationally in this specific operation.

For each patient, his file is presented to an oncology council at the Inter-Balkan Medical Center of Thessaloniki and to a specialized oncology council, while for complex testicular cancers, the file is presented at the Bertonié Oncology Hospital in Bordeaux.

Surgery and follow-up of the patient are guaranteed by a team of experienced urologists, oncologists, vascular surgeons and reproductive biologists.

Erectile dysfunction in young people

Sexual problems are not just a matter for older men. In recent years, erectile dysfunction in young people has occupied us more and more, as the modern way…

Prostate hyperplasia and symptoms

Benign prostatic hyperplasia is one of the most common diseases of the urinary tract. It affects 1 in 2 men over the age of 50 and 8 in 10 over the age of 65.

Robotic surgery for the treatment of prostate cancer

The new technology of robotic surgery is revolutionizing the treatment of prostate cancer